Physician Principal
Health Management Associates
Baltimore, Maryland
Anika Alvanzo, MD, MS, FACP, DFASAM is a graduate of the George Washington University School of Medicine and Health Sciences, holds a master’s degree in biostatistics from Virginia Commonwealth University, and is board certified in Internal Medicine and Addiction Medicine. She is a Physician Principal at Health Management Associates, where her consulting has focused on supporting state and local jurisdictions in community needs assessment and strategic planning for behavioral health service delivery; provision of training, technical assistance, and coaching to behavioral health providers; training on and implementation of the ASAM Criteria; and advancing cultural humility and health equity in addiction treatment. Dr. Alvanzo is a Distinguished Fellow of ASAM and currently serves as Chair of the ASAM Annual Conference Program Planning Committee and Secretary for the ASAM Board of Directors.
With almost two decades of experience in Addiction Medicine, Dr. Alvanzo has held various clinical leadership roles including Regional Medical Director overseeing residential addiction treatment facilities in Maryland and Eastern Pennsylvania. During her twelve years on faculty at Johns Hopkins University School of Medicine, she served as Medical Director of the Broadway Center for Addiction, the opioid treatment program on the campus of Johns Hopkins Hospital (JHH), and Director of the Substance Use Disorders Consultation Service, an inpatient addiction consultation service at JHH. Her publications span topics including gender and race/ethnicity differences in the risk for substance use disorders and the association between psychological trauma, posttraumatic stress, and substance use, particularly in women. Dr. Alvanzo has served as a subject matter expert on national panels, including the National Institutes of Health, Substance Abuse and Mental Health Services Administration, National Quality Forum, and PEW Research Center on topics such as opioids and chronic pain, quality metric development and medication for opioid use disorder (MOUD) integration.
Using Data to Inform and Improve Recovery Equity
Friday, April 25, 2025
10:30 AM – 11:45 AM
Disclosure(s): No financial relationships to disclose